Respiratory therapy services that are provided in a facility are usually the responsibility of the facility’s nursing staff and/or respiratory therapy department.
Payment to a physician may be allowed for respiratory services only when the services are rendered as an integral although incidental part of the physician’s professional services in the course of diagnosis or treatment of an injury or illness. It is expected that respiratory therapy services will most often be used in cases of acute respiratory disease or acute exacerbation of chronic disease. Nevertheless, selected chronic stable conditions could require the services. Acute disease states are expected to either subside after a short period of treatment or, if no response occurs, the patient is transferred to a higher level of care.
- Respiratory therapy services performed in a nursing facility or office setting may be eligible for payment to a physician if one of the following conditions is met:
- The service is personally performed by the physician or qualified non-physician practitioner if provision of the service is within the scope of his license.
Or,
- The service is performed by ancillary personnel employed by the physician, under the direct personal supervision of the physician, and is furnished during a course of treatment in which the physician performs an initial service and subsequent service(s) which reflect his active participation in and management of the course of treatment.
- CPT code 31720 is payable only if it is personally performed by the physician (or qualified non-physician practitioner).
LCD Individual Consideration
Additional payment may be allowed for respiratory therapy treatments and oximetric determinations exceeding the parameters described in the Utilization Guidelines section below on an individual consideration basis. The LCD Individual Consideration procedure is described in the related article.
Notice: This LCD imposes diagnosis limitations that support diagnosis to procedure code automated denials. However, services performed for any given diagnosis must meet all of the indications and limitations stated in this policy, the general requirements for medical necessity as stated in CMS payment policy manuals, any and all existing CMS national coverage determinations, and all Medicare payment rules.
As published in CMS IOM 100-08, Section 13.5.1, to be covered under Medicare, a service shall be reasonable and necessary. When appropriate, contractors shall describe the circumstances under which the proposed LCD for the service is considered reasonable and necessary under Section 1862(a)(1)(A). Contractors shall consider a service to be reasonable and necessary if the contractor determines that the service is:
- Safe and effective.
- Not experimental or investigational (exception: routine costs of qualifying clinical trial services with dates of service on or after September 19, 2000, which meet the requirements of the clinical trials NCD are considered reasonable and necessary).
- Appropriate, including the duration and frequency that is considered appropriate for the service, in terms of whether it is:
- Furnished in accordance with accepted standards of medical practice for the diagnosis or treatment of the patient’s condition or to improve the function of a malformed body member.
- Furnished in a setting appropriate to the patient’s medical needs and condition.
- Ordered and furnished by qualified personnel.
- One that meets, but does not exceed, the patient’s medical need.
- At least as beneficial as an existing and available medically appropriate alternative.
Bill Type Codes
Contractors may specify Bill Types to help providers identify those Bill Types typically used to report this service. Absence of a Bill Type does not guarantee that the policy does not apply to that Bill Type. Complete absence of all Bill Types indicates that coverage is not influenced by Bill Type and the policy should be assumed to apply equally to all claims.
13X, 18X, 21X, 22X, 23X, 73X, 74X, 75X, 77X, 85X
Bill Type Note: Code 73X end-dated for Medicare use March 31, 2010; code 77X effective for dates of service on or after April 1, 2010.
Revenue Codes
Contractors may specify Revenue Codes to help providers identify those Revenue Codes typically used to report this service. In most instances Revenue Codes are purely advisory; unless specified in the policy services reported under other Revenue Codes are equally subject to this coverage determination. Complete absence of all Revenue Codes indicates that coverage is not influenced by Revenue Code and the policy should be assumed to apply equally to all Revenue Codes.
Note: TrailBlazer has identified the Bill Type and Revenue Codes applicable for use with the CPT/HCPCS codes included in this LCD . Providers are reminded that not all CPT/HCPCS codes listed can be billed with all Bill Type and/orRevenue Codes listed. CPT/HCPCS codes are required to be billed with specific Bill Type and Revenue Codes. Providers are encouraged to refer to the CMS Internet-Only Manual Publication 100-04, Claims Processing Manual, for further guidance.
041X, 046X
CPT/HCPCS Codes
Note: | Providers are reminded to refer to the long descriptors of the CPT codes in their CPT book. The American Medical Association (AMA) and the Centers for Medicare & Medicaid Services (CMS) require the use of short CPT descriptors in policies published on the Web. |
31720© | Clearance of airways |
94640© | Airway inhalation treatment |
94664© | Aerosol or vapor inhalations |
ICD-9-CM Codes That Support Medical Necessity
The CPT/HCPCS codes included in this LCD will be subjected to "procedure to diagnosis" editing. The following lists include only those diagnoses for which the identified CPT/HCPCS procedures are covered. If a covered diagnosis is not on the claim, the edit will automatically deny the service as not medically necessary.
Medicare is establishing the following limited coverage for CPT/HCPCS codes 31720, 94640 and 94664:
Covered for:
011.50–011.56 | Tuberculous bronchiectasis |
162.0–162.5 | Malignant neoplasm of trachea, bronchus or lung |
162.8–162.9 | Malignant neoplasm of trachea, bronchus or lung |
163.0–163.1 | Malignant neoplasm of pleura |
163.8–163.9 | Malignant neoplasm of pleura |
197.0 | Secondary malignant neoplasm, lung |
197.2 –197.3 | Secondary malignant neoplasm of respiratory system |
276.7* | Hyperpotassemia Note: Use this code with a diagnosis of hyperkalemia. |
277.00–277.03 | Cystic fibrosis |
277.09 | Cystic fibrosis, with other manifestations |
327.00–327.02 | Organic disorders of initiating and maintaining sleep [Organic insomonia] |
327.09 | Other organic insomnia |
327.10–327.15 | Organic disorders of excessive somnolence [Organic hypersomnia] |
327.19 | Other organic hypersomnia |
327.20–327.27 | Organic sleep apnea |
327.29 | Other organic sleep apnea |
327.30–327.37 | Circadian rhythum sleep disorder |
327.39 | Other circadian rhythum sleep disorder |
327.40–327.44 | Organic parasomnia |
327.49 | Other organic parasomnia |
327.51–327.53 | Organic sleep related movement disorders |
327.59 | Other organic sleep related movement disorders |
327.8 | Other organic sleep related disorders |
398.91 | Rheumatic heart failure (congestive) |
402.01 | Malignant hypertensive heart disease with heart failure |
415.12 | Septic pulmonary embolism |
415.19 | Other pulmonary embolism and infarction |
416.2 | Chronic pulmonary embolism |
416.8-416.9 | Chronic pulmonary heart disease |
428.0 | Congestive heart failure |
464.10–464.11 | Acute tracheitis |
464.20–464.21 | Acute laryngotracheitis |
464.30–464.31 | Acute epiglottitis |
466.0 | Acute bronchitis |
466.11 | Acute bronchiolitis due to Respiratory Syncytial Virus (RSV) |
466.19 | Acute bronchiolitis due to other infectious organisms |
480.0-480.3 | Viral pneumonia |
480.8-480.9 | Viral pneumonia |
481 | Pneumococcal pneumonia [Streptococcus pneumoniae pneumonia] |
482.0–482.2 | Other bacterial pneumonia |
482.30–482.32 | Pneumonia due to streptococcus |
482.39 | Pneumonia due to other streptococcus |
482.40–482.42 | Pneumonia due to staphylococcus |
482.49 | Pneumonia due to other staphylococcus |
482.81–482.84 | Pneumonia due to other specified bacteria |
482.89 | Pneumonia due to other specified bacteria |
482.9 | Bacterial pneumonia unspecified |
483.0–483.1 | Pneumonia due to other specified organism |
483.8 | Pneumonia due to other specified organism |
484.1 | Pneumonia in cytomegalic inclusion disease |
484.3 | Pneumonia in whooping cough |
484.5–484.8 | Pneumonia in other infectious diseases classified elsewhere |
485 | Bronchopneumonia, organism unspecified |
486 | Pneumonia, organism unspecified |
487.0 | Influenza with pneumonia |
491.0–491.1 | Chronic bronchitis |
491.20–491.22 | Obstructive chronic bronchitis |
491.8–491.9 | Chronic bronchitis |
492.0 | Emphysematous bleb |
492.8 | Other emphysema |
493.00–493.02 | Extrinsic asthma |
493.10–493.12 | Intrinsic asthma |
493.20–493.22 | Chronic obstructive asthma |
493.81–493.82 | Other forms of asthma |
493.90–493.92 | Asthma, unspecified |
494.0–494.1 | Bronchiectasis |
495.0–495.9 | Extrinsic allergic alveolitis |
496 | Chronic airway obstruction, not elsewhere classified |
500-505 | Pneumoconioses and other lung diseases due to external agents |
506.0–506.4 | Respiratory conditions due to chemical fumes and vapors |
506.9 | Unspecified respiratory conditions due to fumes and vapors |
507.0–507.1 | Pneumonitis due to solids and liquids |
507.8 | Pneumonitis due to other solids and liquids |
508.1 | Chronic and other pulmonary |
511.81 | Malignant pleural effusion |
511.89 | Other specified forms of effusion, except tuberculous |
511.9 | Unspecified pleural effusion |
513.0–513.1 | Abscess of lung and mediastinum |
514 | Pulmonary congestion and hypostasis |
515 | Post-inflammatory pulmonary fibrosis |
516.0–516.3 | Other alveolar and parietoalveolar pneumonopathy |
516.8–516.9 | Other alveolar and parietoalveolar pneumonopathy |
517.1-517.8 | |
518.0-518.7 | Other diseases of lung |
518.81–518.84 | Other pulmonary insufficiency, not elsewhere classified |
518.89* | Other diseases of lung, not elsewhere classified |
*Note: Use this code for patients who have become oxygen dependent following an illness. | |
519.11 | Acute bronchospasm |
519.19 | Other diseases of trachea and bronchus |
714.81 | Rheumatoid lung |
748.61 | Congenital bronchiectasis |
780.09 | Other alteration of consciousness |
780.51 | Insomnia with sleep apnea |
780.53 | Hypersomnia with sleep apnea |
780.57 | Other and unspecified sleep apnea |
780.97 | Altered mental status |
782.5 | Cyanosis |
786.01–786.07 | Dyspnea and respiratory abnormalities |
786.09 | Other dyspnea and respiratory abnormality |
786.1–786.2 | Dyspnea and respiratory abnormalities |
786.4 | Abnormal sputum |
786.7 | Abnormal chest sounds |
799.01-799.02 | Other ill-defined and unknown causes of morbidity and mortality, asphyxia (hypoxemia) |
995.0 | Other anaphylactic shock |
V10.11-V10.12 | Personal history of malignant neoplasm, trachea, bronchus, lung |
* Note: 276.7 – Use this code with a diagnosis of hyperkalemia.
* Note: 518.89 – Use this code for patients who have become oxygen dependent following an illness.
* Note: 518.89 – Use this code for patients who have become oxygen dependent following an illness.
Note: Providers should continue to submit ICD-9-CM diagnosis codes without decimals on their claim forms and electronic claims.
Diagnoses That Support Medical Necessity
N/A
ICD-9-CM Codes That DO NOT Support Medical Necessity
N/A
Diagnoses That DO NOT Support Medical Necessity
All diagnoses not listed in the “ICD-9-CM Codes That Support Medical Necessity” section of this LCD.
Documentation Requirements
Documentation that supports the medical necessity of the respiratory therapy services and that indicates the services are an integral although incidental part of the physician’s professional services must be included in the patient’s medical records and be available to the carrier upon request. In addition to the physician’s initial assessment (history and physical examination), the documentation might include:
- Physician’s orders.
- Plan of treatment.
- The patient’s response to treatment.
- An ongoing assessment for the patient’s continued need for treatment.
- In case of consecutive days of care, the medical record should indicate why the patient was not transferred to a higher level of care.
- Documentation of frequency must be consistent with the patient plan of care.
When multiple medications are administered and the medications cannot be mixed and administered at one time, the patient’s records must be documented to explain the medical necessity for the separate administrations.
Payment can be allowed for code 31720 only if supporting documentation demonstrates the service was personally performed by the physician or non-physician practitioner when this service falls within his scope of practice.
Documentation supporting medical necessity should be legible, maintained in the patient’s medical record and made available to Medicare upon request.
When requesting a written redetermination (formerly appeal), providers must include all relevant documentation with the request.

0 comments:
Post a Comment